Express News | MyMD Pharmaceuticals Inc - Secured $7 Mln in Commitments in Two Private Placement Funding Rounds Led by Strategic Investor, PharmaCyte Biotech, Inc

ReutersMay 21 09:00 ET

Express News | PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, a Biopharmaceutical Company Focused on Inflammatory Disease

ReutersMay 21 09:00 ET

PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY

PharmaCyte Biotech Interim CEO Silverman to Join Femasys Board >PMCB FEMY

Dow JonesNov 15, 2023 08:37 ET

PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women's Health Innovator Femasys, Inc.

New investment marks expansion of corporate strategy to utilize significant cash position to create additional shareholder value PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") announces it has

BusinesswireNov 15, 2023 08:30 ET

Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech

Femasys Secures $6.85M Additional Financing With Strategic Investment From Investors Led By PharmaCyte Biotech

BenzingaNov 15, 2023 07:32 ET

PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology

Company prepares for comprehensive discussion with FDA to determine appropriate next steps for technology while evaluating additional opportunities PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the

BusinesswireOct 31, 2023 09:15 ET